Free Trial

ADMA Biologics (ADMA) SEC Filings & 10K Form

ADMA Biologics logo
$21.31 +0.08 (+0.38%)
Closing price 04/17/2025 04:00 PM Eastern
Extended Trading
$21.36 +0.05 (+0.26%)
As of 04/17/2025 06:04 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent ADMA Biologics SEC Filings

DateFilerForm TypeView
04/16/2025
8:00 PM
ADMA Biologics (Issuer)
Grossman Adam S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/15/2025
3:40 PM
ADMA Biologics (Filer)
Form ARS
04/15/2025
3:30 PM
ADMA Biologics (Filer)
Form DEF 14A
04/15/2025
3:35 PM
ADMA Biologics (Filer)
Form DEFA14A
04/02/2025
8:00 PM
ADMA Biologics (Issuer)
Kestenberg-Messina Kaitlin M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/21/2025
8:00 PM
ADMA Biologics (Issuer)
Grossman Adam S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2025
8:40 PM
ADMA Biologics (Subject)
Grossman Adam S (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/10/2025
8:00 PM
ADMA Biologics (Issuer)
Kestenberg-Messina Kaitlin M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/10/2025
8:00 PM
ADMA Biologics (Issuer)
Grossman Adam S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2025
8:00 PM
ADMA Biologics (Issuer)
Tade Brad L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2025
8:00 PM
ADMA Biologics (Issuer)
Kestenberg-Messina Kaitlin M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2025
8:00 PM
ADMA Biologics (Issuer)
Grossman Adam S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2025
8:05 PM
ADMA Biologics (Issuer)
FINGER ALISON CECILY (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2025
8:05 PM
ADMA Biologics (Issuer)
Grossman Jerrold B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2025
8:05 PM
ADMA Biologics (Issuer)
ELMS STEVE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2025
8:05 PM
ADMA Biologics (Issuer)
Guiheen Lawrence P. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2025
8:05 PM
ADMA Biologics (Issuer)
Salas Eduardo Rene (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2025
8:05 PM
ADMA Biologics (Issuer)
KWON YOUNG (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2025
8:01 PM
ADMA Biologics (Issuer)
Grossman Adam S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2025
8:01 PM
ADMA Biologics (Issuer)
Kestenberg-Messina Kaitlin M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2025
8:01 PM
ADMA Biologics (Issuer)
Tade Brad L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2025
4:25 PM
ADMA Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/07/2025
12:51 PM
ADMA Biologics (Subject)
Invesco Ltd. (Filed by)
Form SCHEDULE 13G/A
02/03/2025
8:00 PM
ADMA Biologics (Issuer)
Kestenberg-Messina Kaitlin M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2025
6:05 AM
ADMA Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/13/2025
6:10 AM
ADMA Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/03/2025
8:00 PM
ADMA Biologics (Issuer)
Grossman Adam S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2025
8:00 PM
ADMA Biologics (Issuer)
Kestenberg-Messina Kaitlin M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/02/2025
3:15 PM
ADMA Biologics (Issuer)
Salas Eduardo Rene (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/02/2025
3:06 PM
ADMA Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/20/2024
6:05 AM
ADMA Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/02/2024
8:02 PM
ADMA Biologics (Issuer)
ELMS STEVE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/22/2024
8:00 PM
ADMA Biologics (Subject)
Tade Brad L. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/22/2024
8:00 PM
ADMA Biologics (Subject)
Grossman Adam S (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/22/2024
8:05 PM
ADMA Biologics (Issuer)
Grossman Adam S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/22/2024
8:05 PM
ADMA Biologics (Issuer)
Tade Brad L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/21/2024
3:30 PM
ADMA Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/12/2024
12:34 PM
ADMA Biologics (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
11/08/2024
8:21 AM
ADMA Biologics (Subject)
Invesco Ltd. (Filed by)
Form SC 13G
11/07/2024
4:00 PM
ADMA Biologics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/04/2024
10:00 AM
ADMA Biologics (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G
Trump Treasure April 19 (Ad)

Thanks to President Trump… A $900 investment across5 specific cryptos… Could gain 12,000% so quickly that, just 12 months later…

If I’m right about this (like I was before) a modest $900 investment…
10/31/2024
4:25 PM
ADMA Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/17/2024
8:22 AM
ADMA Biologics (Subject)
STATE STREET CORP (Filed by)
Form SC 13G
10/10/2024
8:29 AM
ADMA Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/09/2024
4:25 PM
ADMA Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/02/2024
8:00 PM
ADMA Biologics (Issuer)
Grossman Adam S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/02/2024
8:00 PM
ADMA Biologics (Issuer)
Kestenberg-Messina Kaitlin M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/23/2024
3:27 PM
ADMA Biologics (Subject)
MILLENNIUM MANAGEMENT LLC (Filed by)
Form SC 13G
09/11/2024
8:00 PM
ADMA Biologics (Issuer)
Guiheen Lawrence P. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/09/2024
8:00 PM
ADMA Biologics (Subject)
Guiheen Lawrence P. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/30/2024
8:00 PM
ADMA Biologics (Subject)
Kestenberg-Messina Kaitlin M. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/30/2024
8:02 PM
ADMA Biologics (Issuer)
Grossman Jerrold B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/30/2024
8:05 PM
ADMA Biologics (Issuer)
Kestenberg-Messina Kaitlin M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/29/2024
8:26 PM
ADMA Biologics (Subject)
Grossman Jerrold B (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/27/2024
8:22 PM
ADMA Biologics (Issuer)
Grossman Adam S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/27/2024
8:00 PM
ADMA Biologics (Issuer)
KWON YOUNG (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/26/2024
8:28 PM
ADMA Biologics (Subject)
Grossman Adam S (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/14/2024
8:05 AM
ADMA Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/08/2024
4:00 PM
ADMA Biologics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/26/2024
8:00 PM
ADMA Biologics (Issuer)
Tade Brad L. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
07/26/2024
8:05 PM
ADMA Biologics (Issuer)
Tade Brad L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/26/2024
8:10 PM
ADMA Biologics (Issuer)
Kestenberg-Messina Kaitlin M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/26/2024
4:15 PM
ADMA Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/02/2024
8:00 PM
ADMA Biologics (Issuer)
Grossman Adam S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2024
8:01 PM
ADMA Biologics (Issuer)
Kestenberg-Messina Kaitlin M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/28/2024
3:34 PM
ADMA Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/14/2024
8:00 PM
ADMA Biologics (Issuer)
Grossman Adam S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2024
4:15 PM
ADMA Biologics (Subject)
Grossman Adam S (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/17/2024
8:00 AM
ADMA Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/09/2024
4:01 PM
ADMA Biologics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/09/2024
3:06 PM
ADMA Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:ADMA) was last updated on 4/19/2025 by MarketBeat.com Staff
From Our Partners